FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

41142011000001102: Bosentan 125mg tablets (Cipla EU Ltd) 56 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 23-Nov 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
243501000001117 Bosentan 125mg tablets (Cipla EU Ltd) 56 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
243521000001112 Bosentan 125mg tablets (Cipla EU Ltd) 56 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bosentan 125mg tablets (Cipla EU Ltd) 56 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Bosentan 125mg tablets (Cipla EU Ltd) 56 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Bosentan 125mg tablets (Cipla EU Ltd) 56 tablet Is a Bosentan 125mg tablets 56 tablet true Inferred relationship Existential restriction modifier
Bosentan 125mg tablets (Cipla EU Ltd) 56 tablet Has AMP Bosentan 125mg tablets (Cipla EU Ltd) true Inferred relationship Existential restriction modifier
Bosentan 125mg tablets (Cipla EU Ltd) 56 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Bosentan 125mg tablets (Cipla EU Ltd) 56 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Bosentan true Inferred relationship Existential restriction modifier
Bosentan 125mg tablets (Cipla EU Ltd) 56 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Bosentan 125mg tablets (Cipla EU Ltd) 56 tablet Has specific active ingredient Bosentan monohydrate true Inferred relationship Existential restriction modifier
Bosentan 125mg tablets (Cipla EU Ltd) 56 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Bosentan 125mg tablets (Cipla EU Ltd) 56 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Bosentan 125mg tablets (Cipla EU Ltd) 56 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Bosentan 125mg tablets (Cipla EU Ltd) 56 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Bosentan 125mg tablets (Cipla EU Ltd) 56 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start